fluocinolone acetonide intravitreal implant

DRUG5 trials

Sponsors

Bausch & Lomb Incorporated, Centre Hospitalier Universitaire Dijon, Nantes University Hospital

Conditions

Diabetic Macular EdemaNon-infectious UveitisNoninfectious Posterior UveitisUveitic Macular EdemaUveitis, Posterior

Phase 2

Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants

CompletedNCT00407082

Bausch & Lomb IncorporatedNoninfectious Posterior Uveitis

Start: 2000-12-31End: 2005-09-30Updated: 2011-12-08

Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy

CompletedNCT00468871

Bausch & Lomb IncorporatedNon-infectious Uveitis

Start: 2002-04-30End: 2006-06-30Updated: 2011-12-08

Phase 4

Medico Economic Evaluation of Fluocinolone Acetonide Implant Versus Dexametheasone Implant in Resistant Diabetic Macular Oedema

RecruitingNCT04910503

Centre Hospitalier Universitaire DijonDiabetic Macular Edema

Start: 2021-10-29End: 2030-04-30Target: 106Updated: 2025-05-09

Unknown Phase

Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal Implant

CompletedNCT03145025

Bausch & Lomb IncorporatedUveitis, Posterior

Start: 2017-07-14End: 2019-03-22Updated: 2019-06-21

Frequency and Intensity of Inflammatory Relapses in Patients With Non-infectious Posterior Uveitis Treated With a Fluocinolone Acetonide Implant

Not yet recruitingNCT07423442

Nantes University HospitalNoninfectious Posterior Uveitis, Uveitic Macular Edema, Uveitis, Posterior

Start: 2026-06-01End: 2027-01-01Target: 100Updated: 2026-06-24

Related Papers

Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results.

2008-09-01200 citations